研究業績

論文・出版

2010年


Japan Breast Cancer Research Group (JBCRG)


黒井克昌、柏 喜代美、戸井雅和、中村清吾、岩田広治、大野真司、増田慎三、青儀健二郎、佐藤信昭、笹野公伸


腫瘍内科 6(4): 360-368, 2010

Clinical Significance of the 21-Gene Signature (Oncotype DX) in Hormone Receptor-Positive Early Stage Primary Breast Cancer in the Japanese Population


Toi M, Iwata H, Yamanaka T, Masuda N, Ohno S, Nakamura S, Nakayama T, Kashiwaba M, Kamigaki S, Kuroi K; and the Japan Breast Cancer Research Group-Translational Research


Cancer 2010, July 1: 3113-3118

JBCRG-07


増田慎三


Cancer Board乳癌 3(1): 92, 2010

JBCRG-M02


黒井克昌


Cancer Board乳癌 3(1): 91, 2010.

ALTTO試験.


黒井克昌


Cancer Board乳癌 1(1): 58, 2010.

Economic evaluation of the 21-gene signature (Oncotype DX(®)) in lymph node-negative/positive, hormone receptor-positive early-stage breast cancer based on Japanese validation study (JBCRG-TR03).


近藤正英、星 淑玲、山中竹春、石黒 洋、戸井雅和


Breast Cancer Res Treat. 2010 Nov 17. [Epub ahead of print]

任意団体JBCRG 研究業績